Screener
Vir Biotechnology, Inc. VIR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Restricted cash and cash equivalents, current | 1,929 | 1,922 |
| Equity investments | 4,133 | 6,077 |
| Prepaid expenses and other current assets | 39,084 | 45,143 |
| Total current assets | 573,739 | 514,080 |
| Intangible assets, net | 7,702 | 7,850 |
| Goodwill | 16,937 | 16,937 |
| Property and equipment, net | 50,430 | 55,620 |
| Operating right-of-use assets | 59,391 | 62,099 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s total current assets?
- Vir Biotechnology, Inc. (VIR) reported total current assets of $573.74M in Q2 2026.
- How has Vir Biotechnology, Inc.'s total current assets changed year-over-year?
- Vir Biotechnology, Inc.'s total current assets decreased by 22.0% year-over-year, from $735.71M to $573.74M.
- What is the long-term trend for Vir Biotechnology, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s total current assets has grown at a -7.8% compound annual growth rate (CAGR), from $772.37M to $514.08M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Vir Biotechnology, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude